Bristol-Myers Squibb Rights
CELG.RT
20 hedge funds and large institutions have $5.44M invested in Bristol-Myers Squibb Rights in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
11% more funds holding
Funds holding: 18 → 20 (+2)
5% more capital invested
Capital invested by funds: $5.17M → $5.44M (+$278K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less ownership
Funds ownership: 0.02% → 0.02% (-0%)
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$1.24K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$12 |
| 3 |
IAIM
International Assets Investment Management
Orlando,
Florida
|
+$11 |
| 4 |
AEPWM
Atlantic Edge Private Wealth Management
Jacksonville,
Florida
|
+$1 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mariner
Overland Park,
Kansas
|
-$1.15K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$688 |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$121 |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$41 |
| 5 |
Morgan Stanley
New York
|
-$10 |
CELG.RT Hedge Fund Activity: Q1 2024 in Review
20 of the 6,945 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Rights (CELG.RT) for Q1 2024, worth a combined $5.44M — up 5.4% from $5.17M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CELG.RT positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 5 trimmed.
The largest buyer was CAPTRUST Financial Advisors, opening a new position worth an estimated $1.24K. The largest seller was Mariner, exiting entirely with an estimated $1.15K sold.
- 20 institutional investors held Bristol-Myers Squibb Rights (CELG.RT) as of Q1 2024, up from 18 in Q4 2023.
- Funds reported $5.44M of Bristol-Myers Squibb Rights stock for Q1 2024, up 5.4% quarter-over-quarter.
- 3 funds opened new Bristol-Myers Squibb Rights positions in Q1 2024 and 1 closed out, a net change of +2 holders.
- The largest Bristol-Myers Squibb Rights buyer in Q1 2024 was CAPTRUST Financial Advisors, an estimated $1.24K added.
- The largest Bristol-Myers Squibb Rights seller in Q1 2024 was Mariner, an estimated $1.15K sold.
Based on aggregated 13F filings for Q1 2024.